vs
Avantor, Inc.(AVTR)とBRINKER INTERNATIONAL, INC(EAT)の財務データ比較。上の社名をクリックして会社を切り替えられます
Avantor, Inc.の直近四半期売上が大きい($1.7B vs $1.5B、BRINKER INTERNATIONAL, INCの約1.1倍)。BRINKER INTERNATIONAL, INCの純利益率が高く(8.8% vs 3.1%、差は5.7%)。BRINKER INTERNATIONAL, INCの前年同期比売上増加率が高い(6.9% vs -1.4%)。BRINKER INTERNATIONAL, INCの直近四半期フリーキャッシュフローが多い($155.2M vs $117.2M)。過去8四半期でBRINKER INTERNATIONAL, INCの売上複合成長率が高い(13.9% vs -0.5%)
アバンター社は米国ペンシルベニア州ラドノーに本社を置くバイオテクノロジー・化学・医薬品企業です。1904年にJ.T.ベイカーとして創業し2010年に現社名に変更、2019年にNY証券取引所に上場し、証券コードは「AVTR」で、世界中のライフサイエンス分野の顧客に製品を提供しています。
ブリンカー・インターナショナルはアメリカの多国籍外食企業で、1975年に設立され、本社はテキサス州ダラスに所在する。傘下に「チリーズ」と「マジアーノズ・リトルイタリー」の2つのレストランチェーンを展開し、世界中で合計1672店舗を直営またはフランチャイズ運営している。
AVTR vs EAT — 直接比較
損益計算書 — Q4 FY2025 vs Q2 FY2026
| 指標 | ||
|---|---|---|
| 売上 | $1.7B | $1.5B |
| 純利益 | $52.4M | $128.5M |
| 粗利率 | 31.5% | — |
| 営業利益率 | 7.6% | 11.6% |
| 純利益率 | 3.1% | 8.8% |
| 売上前年比 | -1.4% | 6.9% |
| 純利益前年比 | -89.5% | 8.4% |
| EPS(希薄化後) | $0.08 | $2.86 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.7B | $1.5B | ||
| Q3 25 | $1.6B | $1.3B | ||
| Q2 25 | $1.7B | $1.5B | ||
| Q1 25 | $1.6B | $1.4B | ||
| Q4 24 | $1.7B | $1.4B | ||
| Q3 24 | $1.7B | $1.1B | ||
| Q2 24 | $1.7B | $1.2B | ||
| Q1 24 | $1.7B | $1.1B |
| Q4 25 | $52.4M | $128.5M | ||
| Q3 25 | $-711.8M | $99.5M | ||
| Q2 25 | $64.7M | $107.0M | ||
| Q1 25 | $64.5M | $119.1M | ||
| Q4 24 | $500.4M | $118.5M | ||
| Q3 24 | $57.8M | $38.5M | ||
| Q2 24 | $92.9M | $57.3M | ||
| Q1 24 | $60.4M | $48.7M |
| Q4 25 | 31.5% | — | ||
| Q3 25 | 32.4% | — | ||
| Q2 25 | 32.9% | — | ||
| Q1 25 | 33.8% | — | ||
| Q4 24 | 33.4% | — | ||
| Q3 24 | 32.9% | — | ||
| Q2 24 | 34.1% | — | ||
| Q1 24 | 34.0% | — |
| Q4 25 | 7.6% | 11.6% | ||
| Q3 25 | -40.0% | 8.7% | ||
| Q2 25 | 7.7% | 9.8% | ||
| Q1 25 | 9.3% | 11.0% | ||
| Q4 24 | 37.8% | 11.5% | ||
| Q3 24 | 7.3% | 5.0% | ||
| Q2 24 | 10.3% | 6.1% | ||
| Q1 24 | 8.7% | 6.2% |
| Q4 25 | 3.1% | 8.8% | ||
| Q3 25 | -43.8% | 7.4% | ||
| Q2 25 | 3.8% | 7.3% | ||
| Q1 25 | 4.1% | 8.4% | ||
| Q4 24 | 29.7% | 8.7% | ||
| Q3 24 | 3.4% | 3.4% | ||
| Q2 24 | 5.5% | 4.7% | ||
| Q1 24 | 3.6% | 4.3% |
| Q4 25 | $0.08 | $2.86 | ||
| Q3 25 | $-1.04 | $2.17 | ||
| Q2 25 | $0.09 | $2.31 | ||
| Q1 25 | $0.09 | $2.56 | ||
| Q4 24 | $0.73 | $2.61 | ||
| Q3 24 | $0.08 | $0.84 | ||
| Q2 24 | $0.14 | $1.22 | ||
| Q1 24 | $0.09 | $1.08 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | ||
|---|---|---|
| 現金・短期投資手元流動性 | $365.4M | $15.0M |
| 総負債低いほど良い | $3.9B | $451.3M |
| 株主資本純資産 | $5.6B | $379.3M |
| 総資産 | $11.8B | $2.7B |
| 負債/資本比率低いほどレバレッジが低い | 0.71× | 1.19× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $365.4M | $15.0M | ||
| Q3 25 | $251.9M | $33.6M | ||
| Q2 25 | $449.4M | $18.9M | ||
| Q1 25 | $315.7M | $17.5M | ||
| Q4 24 | $261.9M | $14.8M | ||
| Q3 24 | $285.3M | $16.2M | ||
| Q2 24 | $272.6M | $64.6M | ||
| Q1 24 | $234.9M | $15.5M |
| Q4 25 | $3.9B | $451.3M | ||
| Q3 25 | $3.9B | $525.8M | ||
| Q2 25 | $4.2B | $426.0M | ||
| Q1 25 | $4.1B | $518.3M | ||
| Q4 24 | $4.1B | $652.0M | ||
| Q3 24 | $4.9B | $806.9M | ||
| Q2 24 | $5.1B | $786.3M | ||
| Q1 24 | $5.3B | $818.5M |
| Q4 25 | $5.6B | $379.3M | ||
| Q3 25 | $5.6B | $343.9M | ||
| Q2 25 | $6.3B | $370.9M | ||
| Q1 25 | $6.1B | $259.0M | ||
| Q4 24 | $6.0B | $131.5M | ||
| Q3 24 | $5.6B | $12.7M | ||
| Q2 24 | $5.4B | $39.4M | ||
| Q1 24 | $5.3B | $-46.7M |
| Q4 25 | $11.8B | $2.7B | ||
| Q3 25 | $11.7B | $2.7B | ||
| Q2 25 | $12.8B | $2.7B | ||
| Q1 25 | $12.3B | $2.6B | ||
| Q4 24 | $12.1B | $2.6B | ||
| Q3 24 | $12.8B | $2.5B | ||
| Q2 24 | $12.7B | $2.6B | ||
| Q1 24 | $12.8B | $2.5B |
| Q4 25 | 0.71× | 1.19× | ||
| Q3 25 | 0.69× | 1.53× | ||
| Q2 25 | 0.67× | 1.15× | ||
| Q1 25 | 0.67× | 2.00× | ||
| Q4 24 | 0.68× | 4.96× | ||
| Q3 24 | 0.89× | 63.54× | ||
| Q2 24 | 0.94× | 19.96× | ||
| Q1 24 | 1.00× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | ||
|---|---|---|
| 営業キャッシュフロー直近四半期 | $152.7M | $218.9M |
| フリーキャッシュフロー営業CF - 設備投資 | $117.2M | $155.2M |
| FCFマージンFCF / 売上 | 7.0% | 10.7% |
| 設備投資強度設備投資 / 売上 | 2.1% | 4.4% |
| キャッシュ転換率営業CF / 純利益 | 2.91× | 1.70× |
| 直近12ヶ月FCF直近4四半期 | $495.0M | $455.9M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $152.7M | $218.9M | ||
| Q3 25 | $207.4M | $120.8M | ||
| Q2 25 | $154.4M | $186.0M | ||
| Q1 25 | $109.3M | $212.0M | ||
| Q4 24 | $173.3M | $218.2M | ||
| Q3 24 | $244.8M | $62.8M | ||
| Q2 24 | $281.1M | $141.5M | ||
| Q1 24 | $141.6M | $130.1M |
| Q4 25 | $117.2M | $155.2M | ||
| Q3 25 | $171.7M | $62.2M | ||
| Q2 25 | $124.8M | $106.1M | ||
| Q1 25 | $81.3M | $132.4M | ||
| Q4 24 | $145.8M | $168.9M | ||
| Q3 24 | $204.0M | $6.3M | ||
| Q2 24 | $235.3M | $83.5M | ||
| Q1 24 | $106.9M | $78.7M |
| Q4 25 | 7.0% | 10.7% | ||
| Q3 25 | 10.6% | 4.6% | ||
| Q2 25 | 7.4% | 7.3% | ||
| Q1 25 | 5.1% | 9.3% | ||
| Q4 24 | 8.6% | 12.4% | ||
| Q3 24 | 11.9% | 0.6% | ||
| Q2 24 | 13.8% | 6.9% | ||
| Q1 24 | 6.4% | 7.0% |
| Q4 25 | 2.1% | 4.4% | ||
| Q3 25 | 2.2% | 4.3% | ||
| Q2 25 | 1.8% | 5.5% | ||
| Q1 25 | 1.8% | 5.6% | ||
| Q4 24 | 1.6% | 3.6% | ||
| Q3 24 | 2.4% | 5.0% | ||
| Q2 24 | 2.7% | 4.8% | ||
| Q1 24 | 2.1% | 4.6% |
| Q4 25 | 2.91× | 1.70× | ||
| Q3 25 | — | 1.21× | ||
| Q2 25 | 2.39× | 1.74× | ||
| Q1 25 | 1.69× | 1.78× | ||
| Q4 24 | 0.35× | 1.84× | ||
| Q3 24 | 4.24× | 1.63× | ||
| Q2 24 | 3.03× | 2.47× | ||
| Q1 24 | 2.34× | 2.67× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
AVTR
| Laboratory Solutions Segment | $1.1B | 67% |
| Bioscience Production Segment | $547.5M | 33% |
EAT
| Chilis Restaurants | $1.3B | 91% |
| Maggianos Restaurants | $134.9M | 9% |
| Franchise Revenues | $13.4M | 1% |